Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSome people taking Wegovy (semaglutide) notice they feel cold more easily than usual, particularly in the hands and feet. This is a recognised pattern reported during GLP-1 treatment, most commonly linked to the significant calorie reduction that comes with reduced appetite. It is not listed as a direct pharmacological side effect in the Wegovy SmPC, but it is something our prescribers hear about regularly. Wegovy is a prescription-only medicine; a clinical assessment determines whether it is suitable for you, and any symptoms you experience during treatment should be discussed with your prescribing team.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The short answer is: not directly. The NHS patient information for semaglutide lists the most common side effects as gastrointestinal, including nausea, vomiting, diarrhoea, constipation and indigestion. Feeling persistently cold does not appear in that primary list. The Wegovy SmPC, published on the electronic Medicines Compendium, mirrors this, with no entry for altered body temperature as a direct effect of the drug.
That said, the absence from the side-effect list does not mean the experience is imaginary. What it usually means is that the cold feeling is a downstream consequence of something the medicine does very well: helping people eat significantly less. The body generates warmth partly through the process of digesting and metabolising food. Eat considerably less, as most Wegovy users do, and that internal heat source is reduced.
There is also a separate consideration worth knowing about. When body fat decreases, one of its roles as insulation is reduced. Over weeks and months of weight loss, some people notice they need an extra layer in rooms that never bothered them before. This is a physiological response to losing fat mass, not a signal that something is wrong. You can find a fuller breakdown of the broader side-effect picture on our Wegovy side effects overview.
When appetite falls sharply, as it does for many people on semaglutide, the total amount of energy coming in drops. Your body's resting metabolic rate adjusts, and one of the first things that shifts is the warmth produced by digestion, a process called diet-induced thermogenesis. Essentially, your gut is doing less work, so it produces less heat as a by-product.
Cold extremities, particularly fingers and toes, are especially common because the body prioritises blood flow to vital organs when overall energy intake is low. This is a normal physiological response, not a sign of a circulation problem in most cases. A practical check you can do in under a minute: press gently on a fingernail, let go, and watch the colour return. Normal return within two seconds suggests peripheral circulation is intact. If the return is slow and your hands are persistently numb rather than just cool, mention it at your next check-in.
If you want to understand whether being cold is a side effect of Wegovy or simply a result of eating less, our dedicated page walks through the distinction in detail. For many users who notice Wegovy side effects such as feeling cold, the sensation becomes less noticeable once the body adapts and eating patterns stabilise at the new, lower level. Keeping protein intake adequate and staying well hydrated can support your metabolism during this phase; your prescribing team can advise on specifics.
Mild, occasional cold sensitivity during Wegovy treatment is unlikely to be dangerous. However, there are situations where you should contact your prescriber or seek urgent care promptly.
Severe and unexplained chills alongside stomach pain, particularly pain that radiates to the back, could point to pancreatitis, a rare but serious condition. In January 2026, the MHRA issued a Drug Safety Update reminding prescribers and patients that acute pancreatitis is a known, infrequent risk with GLP-1 medicines; persistent, severe abdominal pain is the key warning sign, and you should seek urgent medical attention if it occurs.
Separately, if cold feelings come with dizziness, rapid heart rate, excessive sweating, or confusion, these could indicate dehydration from significant nausea or vomiting. Dehydration reduces blood volume, which can cause cold, clammy skin and is something that needs prompt attention, especially if you have been unable to keep fluids down for more than 24 hours.
Cold intolerance that is out of proportion to your weight loss, or that develops suddenly without another explanation, can occasionally reflect a thyroid issue unrelated to the medicine. A simple blood test ordered by your GP or prescriber can rule this out.
Suspected side effects, including cold sensitivity that concerns you, can be reported directly to the MHRA via the Yellow Card scheme. Reporting helps build the post-market safety picture for all GLP-1 medicines.
Feeling cold during weight loss is rarely a reason to stop treatment. It is worth putting in context: meaningful weight loss, of the kind that Wegovy supports, carries well-established health benefits for blood pressure, blood sugar and cardiovascular risk. A mild need for an extra jumper in the evenings is, for most people, an acceptable trade-off.
That said, everyone's experience differs, and individual suitability is always a clinical question. Some patients notice no side effects on Wegovy at all, which is reassuring but can itself raise questions about whether the medicine is working as expected. If you are already on treatment and struggling, reaching out to our aftercare team is the right move, not quietly stopping your pen.
If you are still in the research stage, our Wegovy treatment guide covers how the medicine works, what the clinical trial evidence shows, and how a private prescription through a GPhC-registered pharmacy like ours compares with waiting for NHS access. Those earlier in the titration process may also find it helpful to read about Wegovy .5 side effects, since the starting dose brings its own pattern of effects that differ from later stages. The free consultation is the starting point; our prescribers go through your full health picture before any prescription is issued.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.